Inhibition of O‐GalNAc glycosylation or knockdown of Galnt9 demonstrates efficacy in restraining the liver metastasis of NEPC, small cell lung cancer (SCLC), and colorectal neuroendocrine cancer. The gene discussed is GALNT9; the disease is small cell lung carcinoma.